Survival Among Patients with Platinum Resistant, Locally Advanced Non-Small Cell Lung Cancer Treated with Platinum-Based Systemic Therapy

被引：0
|
作者：
Thomas A. d’Amato
Brian L. Pettiford
Mathew J. Schuchert
Ricardo Parker
William A. Ricketts
James D. Luketich
Rodney J. Landreneau
机构：
[1] Forum Health—Western Reserve Health System,
[2] University of Pittsburgh Medical Center,undefined
[3] Oncotech,undefined
[4] Inc.,undefined
来源：
Annals of Surgical Oncology | 2009年 / 16卷
关键词：
Epidermal Growth Factor Receptor; Chemotherapy Resistance; Platinum Agent; Tumor Biopsy Specimen; Doublet Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2848 / 2855
页数：7
相关论文
共 50 条
  • [1] Survival Among Patients with Platinum Resistant, Locally Advanced Non-Small Cell Lung Cancer Treated with Platinum-Based Systemic Therapy
    d'Amato, Thomas A.
    Pettiford, Brian L.
    Schuchert, Mathew J.
    Parker, Ricardo
    Ricketts, William A.
    Luketich, James D.
    Landreneau, Rodney J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (10) : 2848 - 2855
  • [2] Survival among patients with platinum resistant, locally advanced non-small cell cancer (stage II and III) treated with platinum-based systemic therapy
    D'Amato, T. A.
    Pettiford, B. L.
    Schuchert, M. J.
    McKenna, R. J.
    Cerfolio, R. J.
    Ricketts, W. A.
    Santos, R. S.
    Luketich, J. D.
    Landreneau, R. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 28 - 28
  • [3] Weekly paclitaxel for advanced non-small cell lung cancer patients not suitable for platinum-based therapy
    Juan, O
    Albert, A
    Villarroya, T
    Sánchez, R
    Casan, R
    Caranana, V
    Campos, JM
    Alberola, V
    [J]. NEOPLASMA, 2003, 50 (03) : 204 - 209
  • [4] Prognostic model in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
    Radosavljevic, D. Z.
    Gavrilovic, D.
    Golubicic, I.
    Jelic, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] European perspectives on paclitaxel/platinum-based therapy for advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 3 - 9
  • [6] Evaluation of Platinum-based Therapy Response in Non-Small Cell Lung Cancer
    Ippolito, M.
    Stefano, A.
    Russo, G.
    Gieri, S.
    Cosentino, S.
    Mure, G.
    Baldari, S.
    Sabini, M. G.
    Fraggetta, F.
    Vitabile, S.
    Gilardi, M. C.
    Banna, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S714 - S715
  • [7] Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
    Sutandyo, Noorwati
    Hanafi, Arif Riswahyudi
    Jayusman, Achmad Mulawarman
    Kurniawati, Sri Agustini
    Hanif, Muhamad Alfin
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 85 - 93
  • [8] Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    Sullivan, Ivana
    Salazar, Juliana
    Majem, Margarita
    Pallares, Cinta
    del Rio, Elisabeth
    Paez, David
    Baiget, Montserrat
    Barnadas, Agusti
    [J]. CANCER LETTERS, 2014, 353 (02) : 160 - 166
  • [9] Haplotypes of BRCA1 and survival of non-small cell lung cancer patients treated with platinum-based chemotherapy
    Ryu, J.
    Shin, E.
    Lee, J.
    Yoo, Y.
    Cho, J.
    Kim, H.
    Lee, E.
    Kim, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Lee, Seung Hyeun
    Park, Myung Jae
    Park, So Young
    In, Kwang Ho
    Kim, Chul Hwan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S959 - S960
12345